Appendix 3B - Proposed issue of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement 24/2/2025 The Proposed issue is: A placement or other

THERAPEUTICS LIMITED

of this announcement

placement or other type of issue

number of +securities proposed to be issued for a placement or other type of issue

to next page for full details of the announcement

1 - Entity and announcement details

THERAPEUTICS LIMITED

(the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of

the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing

the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation

of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing

Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance

with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for

Date of this announcement

The Proposed issue is:

placement or other type of issue

7 - Details of proposed placement or other issue

Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on

an unconditional basis?

of +securities proposed to be issued

Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)

of +securities proposed to be issued

the +securities proposed to be issued being issued for a cash consideration?

describe the consideration being provided for the +securities

provide an estimate of the AUD equivalent of the consideration being provided for the +securities

Will all the +securities issued in this class rank equally in all respects from their issue date?

of the type of +security that will be issued if the option is exercised

: ORDINARY FULLY PAID

Number of securities that will be issued

if the option is exercised

provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide

the information by separate announcement.

Proposed +issue date

Listing Rule requirements

Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?

Date of meeting or proposed meeting to approve the issue under listing rule 7.1

Is a party referred to in listing rule 10.11 participating in the proposed issue?

7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?

Will any of the +securities to be issued be subject to +voluntary escrow?

Will there be a lead manager or broker to the proposed issue?

7E.2 Is the proposed issue to be underwritten?

7E.4 Details of any other material fees

or costs to be incurred by the entity in connection with the proposed issue

7F.01 The purpose(s) for which the entity

is issuing the securities

Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?

7F.2 Any other information the entity

wishes to provide about the proposed issue

Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions

in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:

publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)